Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
{{output}}
Background: Semaglutide at a dose of 2.4 mg has established weight-loss and cardiovascular benefits, and cagrilintide at a dose of 2.4 mg has shown promising results in early-phase trials; the efficacy of the combination (known a... ...
